A Glasgow clinic that assesses and treats ADHD and autism, Diverse Diagnostics, is acquired by investment firm Broadlake as part of a plan to expand its neurodiversity services. Both outlets report the acquisition is tied to future growth beyond the clinic’s current base in Glasgow.

The reports agree on the core details: Diverse Diagnostics is Glasgow-based, focuses on ADHD and autism assessments, and will be supported by Broadlake to extend services across the UK. They differ slightly in the emphasis and level of detail. The Glasgow Times frames the move as a “major expansion” and notes that the purchase price is undisclosed. The Herald Scotland emphasizes the broader UK rollout of neurodiversity services, positioning the acquisition as an expansion of its national offering.

Together, the articles present the same transaction from two angles—local expansion in Glasgow versus a UK-wide scaling of services—without adding further operational or financial specifics.